Investing.com - Portage Biotech Inc (NASDAQ: PRTG) reported third quarter EPS of $-1.88, $1.61 worse than the analyst estimate of $-0.27. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.
Portage Biotech Inc's stock price closed at $0.71. It is down -47.41% in the last 3 months and down -79.77% in the last 12 months.
Portage Biotech Inc saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Portage Biotech Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Portage Biotech Inc's Financial Health score is "weak performance".
Check out Portage Biotech Inc's recent earnings performance, and Portage Biotech Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar